Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.

Saruc M., Ozden N., Turkel N., Ayhan S., Hock L., Tuzcuoglu I., ...More

Journal of pharmaceutical sciences, vol.92, pp.1386-95, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 92
  • Publication Date: 2003
  • Doi Number: 10.1002/jps.10401
  • Journal Name: Journal of pharmaceutical sciences
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1386-95
  • Keywords: chronic hepatitis B, thymosin-alpha 1, interferon alpha-2b, hepatitis B e antigen (HBeAg) negative, ALPHA-INTERFERON, UNTREATED PATIENTS, LAMIVUDINE, VIRUS, EFFICACY, INFECTION, MUTATIONS, TRENDS, TRIAL
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No